Evidence map›Paper›PMID 42557511›Full record

ArticleScience China. Life sciences2026

Ultrasound-targeted cavitation induced tumor vascular normalization and radiotherapy sensitization in breast cancer.

Zichao Liu, Huai Yang, Zenan Zhang, Chenke Kuang, Liyong Deng, Yueyong Li, Linyuan Jin, Hongjun Nie, Guihua Wang, Meng Du and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Science China. Life sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Zichao Liu *Key Laboratory of Medical Imaging Precision Theranostics and Radiation Protection, College of Hunan Province, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, 410004, China.
Huai Yang *Key Laboratory of Medical Imaging Precision Theranostics and Radiation Protection, College of Hunan Province, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, 410004, China.
Zenan Zhang *Key Laboratory of Medical Imaging Precision Theranostics and Radiation Protection, College of Hunan Province, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, 410004, China.
Chenke KuangKey Laboratory of Medical Imaging Precision Theranostics and Radiation Protection, College of Hunan Province, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, 410004, China.
Liyong DengDepartment of Oncology, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, 410004, China.
Yueyong LiDepartment of Oncology, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, 410004, China.
Linyuan JinDepartment of Ultrasound Medicine, Department of Medical Imaging, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, 410004, China.
Hongjun NieDepartment of Ultrasound Medicine, Department of Medical Imaging, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, 410004, China.
Guihua WangDepartment of Oncology, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, 410004, China. wangguihua8890@163.com.
Meng DuKey Laboratory of Medical Imaging Precision Theranostics and Radiation Protection, College of Hunan Province, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, 410004, China. dumeng_work@126.com.
Zhiyi ChenKey Laboratory of Medical Imaging Precision Theranostics and Radiation Protection, College of Hunan Province, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, 410004, China. zhiyi_chen@usc.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The limited therapeutic efficacy of radiotherapy (RT) in breast cancer is closely linked to hypoxia, which is caused by structurally abnormal vascular networks in the tumor microenvironment (TME). Tumor vascular normalization has emerged as a promising strategy to enhance radiosensitization by alleviating hypoxia. However, current vascular normalization methods face critical limitations, including off-target effects and inadequate spatiotemporal precision. Therefore, developing precise and efficient vascular normalization strategies is crucial for improving RT efficacy. In this study, we developed a tumor vascular normalization strategy based on ultrasound-targeted cavitation for radiosensitization. We synthesized VEGFR2-targeted microbubbles (MB@VEGFR2) to selectively accumulate on tumor vascular endothelial cells. Ultrasound-targeted cavitation enhanced local tumor blood perfusion, increased vascular diameter and maturity, and effectively alleviated hypoxia. By monitoring the time window of vascular normalization and administering RT within this period, tumor growth was significantly suppressed, with a 2.5-fold reduction in tumor volume compared to RT alone. Mechanistically, ultrasound-targeted cavitation promoted ATP release from endothelial cells, activating the PI3K/AKT/eNOS pathway to elevate nitric oxide (NO) production by 4-fold, thereby inhibiting abnormal vascular formation. This study demonstrates that ultrasound-targeted cavitation precisely achieves tumor vascular normalization, effectively improving RT efficacy.

Indexed as

breast cancerradiotherapyultrasound-targeted cavitationvascular normalizationVEGFR2-targeted microbubble

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.